KMPHARMACEUTICAL Co.,Ltd.

KOSDAQ:A225430 Stock Report

Market Cap: ₩19.8b

KMPHARMACEUTICALLtd Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Il-Mo Kang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership37.3%
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates


CEO

Il-Mo Kang (57 yo)

no data

Tenure

Mr. Il-Mo Kang serves as the Chief Executive Officer of Km Pharmaceutical Co., Ltd.